IL6 and COVID-19: Many of the already-known disease hallmarks of COVID-19 have been shown to be associated with circulating serum concentrations of specific miRNAs, for instance miR-424, in the likelihood of a thromboembolic event [42], and miR-766-3p in its association with IL-6-related hyperinflammation [19].